CN Stock MarketDetailed Quotes

605177 Zhejiang East-Asia Pharmaceutical

Watchlist
  • 18.60
  • +0.86+4.85%
Market Closed Sep 27 15:00 CST
2.13BMarket Cap21.53P/E (TTM)

About Zhejiang East-Asia Pharmaceutical Company

The company was founded in 1998 and has successively won titles such as “National High-tech Enterprise”, “Zhejiang Patent Demonstration Enterprise”, and “Taizhou Top Ten Management Innovation Enterprises”. It also has a provincial research institute and a provincial enterprise technology center, and has undertaken many national torch plan projects. The company and its subsidiaries have applied for more than 30 national invention patents, obtained 27 national invention patents, and 1 PCT international patent. The company is mainly engaged in R&D, production and sales of chemical raw materials and pharmaceutical intermediates. The company's products mainly cover various fields of use, such as antibacterial drugs (beta-lactams and quinolones), anticholinergic and synthetic antispasmodics (trimebutine maleate), and dermatological antifungal drugs. The company has successively won titles such as “National High-tech Enterprise”, “Zhejiang Patent Demonstration Enterprise”, and “Taizhou Top Ten Management Innovation Enterprises”.

Company Profile

Short Name-A东亚药业
Symbol-A605177
Company NameZhejiang East-Asia Pharmaceutical Co., Ltd.
Listing DateNov 25, 2020
Issue Price31.13
Shares Offered28.40M share(s)
FoundedFeb 6, 1998
Listed ExchangeSH Stock Exchange
Legal Representativezhengming chi
General Managercheng chi
Secretaryjianbo zhou
Accounting FirmZhonghui Certified Public Accountants (Special General Partnership)
Securities Representativexiaodan jia
Legal CounselShanghai Tongli Law Firm
Employees372
Phone0576-89185661
Office Address23rd Floor, Chamber of Commerce Building, 118 Laodong North Road, Huangyan District, Taizhou, Zhejiang
Zip Code318020
Registered AddressCoastal Industrial City, Pubagang Town, Sanmen County, Taizhou City, Zhejiang Province
Fax0576-84285399
Emaildyzqb@eapharm.net
Business License331022000001126
BusinessT APIs (erdostane, ofloxacin, ketoconazole, loratadine, tiopronin, levofloxacin hydrochloride, levofloxacin hydrochloride, terbinafine hydrochloride, trimebutine maleate, levofloxacin, thioconazole, epastat, donepezil hydrochloride, clopidogrel hydrochloride, olmesartan, esomeprazole magnesium, hexafloxacin hydrochloride, tenofovir dipyrrolide fumarate, aripiprazole); manufacture, tablets Manufacture of granules and capsules (operated with a valid license); manufacture of inorganic salts (excluding hazardous chemicals and chemicals that are easy to produce drugs); road freight operations; special chemical equipment and hardware Sales of products and steel; import and export of technology and import and export of goods.

Company Executives

  • Name
  • Position
  • Salary
  • zhengming chi
  • Chairman, Directors, Chairman of the Strategy Committee
  • 1.88M
  • daomin xia
  • Directors, Deputy General Manager, Deputy Chairman of the Remuneration and Assessment Committee
  • 1.14M
  • cheng chi
  • Directors, General Manager, Member of the Strategy Committee
  • 1.30M
  • jiangli qian
  • Directors, Deputy Chairman of the Nomination Committee, Deputy Chairman of the Audit Committee
  • 80.00K
  • yan feng
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 80.00K
  • sunliang cui
  • Independent Directors, Chairman of the Nomination Committee, Audit Committee Member, Member of the Strategy Committee
  • 80.00K
  • fangzhong qi
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
  • 80.00K
  • jianbo zhou
  • Board Secretary
  • --
  • xiaodan jia
  • Securities Affairs Representative
  • --
  • jing xu
  • Chairman of the Supervisory Board, Auditors
  • 159.30K
  • risheng li
  • Auditors
  • 471.40K
  • lingzhi chen
  • Deputy General Manager
  • 706.80K
  • xiaomin wang
  • Head of Finance
  • 730.00K
  • wenbin liu
  • Employee Supervisors
  • 161.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data